Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (8)

2020

  1. Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

    British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683

  2. Recovery time after oral and maxillofacial ambulatory surgery with dexmedetomidine: an observational study

    Clinical Oral Investigations, Vol. 23, Núm. 1, pp. 391-397

2017

  1. Effect of dexmedetomidine and propofol on basal ganglia activity in Parkinson disease a controlled clinical trial

    Anesthesiology, Vol. 126, Núm. 6, pp. 1033-1042

2014

  1. A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients

    AAPS Journal, Vol. 16, Núm. 3, pp. 609-619

2000

  1. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 295, Núm. 1, pp. 352-359

1999

  1. Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: Application to pharmacokinetic studies

    Chirality, Vol. 11, Núm. 4, pp. 272-279

  2. Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 724, Núm. 1, pp. 83-89